You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LP-108

Showing 1 - 25 of 841
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial (LP-108, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • (no location specified)
Nov 29, 2022

AML/MDS, CMML, Relapse Trial in China, Spain, United States (LP-108, LP-108 and azacitidine)

Recruiting
  • AML/MDS
  • +5 more
  • LP-108
  • LP-108 and azacitidine
  • Ann Arbor, Michigan
  • +7 more
Feb 14, 2022

Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Nanjing (LP-108 tablet)

Unknown status
  • Non-Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • LP-108 tablet
  • Nanjing, Jiangsu, China
    the First Affiliated Hospital of Nanjing Medical University
Jul 8, 2020

Relapsed or Refractory Lymphomas, Advanced Solid Tumor Trial in Los Alamitos (LP-284)

Not yet recruiting
  • Relapsed or Refractory Lymphomas
  • Advanced Solid Tumor
  • Los Alamitos, California
    Cancer and Blood Specialty Clinic
Nov 9, 2023

Post-intensive Care Syndrome, Transitional Care, Critical Care Trial in Pittsburgh (PICTURE-THIS, Enhanced Usual Care, Run-In

Recruiting
  • Post-intensive Care Syndrome
  • +3 more
  • PICTURE-THIS
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Oct 10, 2023

HIV Trial in Worldwide (Cabotegravir Tablets, Cabotegravir Injectable Suspension (CAB LA), Rilpivirine Tablets)

Active, not recruiting
  • HIV Infections
  • Cabotegravir Tablets
  • +4 more
  • Bakersfield, California
  • +116 more
Jan 22, 2023

Advanced Solid Tumor Trial in Los Alamitos (LP-184)

Recruiting
  • Advanced Solid Tumor
  • Los Alamitos, California
    Cancer and Blood Specialty Clinic
Jul 3, 2023

Advanced Solid Tumor Trial in China (IO-108, IO-108 + pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • IO-108
  • IO-108 + pembrolizumab
  • Changsha, Hunan, China
  • +3 more
Aug 18, 2022

Lipoprotein(a) and Endogenous Fibrinolysis in Atherosclerotic

Recruiting
  • Atherosclerosis
  • Aortic Valve Disease
  • Thrombotic assessment
  • Measurement of Lp(a)
  • Stevenage, United Kingdom
    East and North Herts NHS Trust
Nov 6, 2023

Atherosclerotic Cardiovascular Disease Trial in Worldwide (Lp(a) Screening)

Recruiting
  • Atherosclerotic Cardiovascular Disease
  • Lp(a) Screening
  • Birmingham, Alabama
  • +670 more
Feb 1, 2023

Chronic Idiopathic Urticaria, Chronic Idiopathic Pruritus, Lichen Planus Trial in United States (KPL-716, Placebo)

Completed
Has Results
  • Chronic Idiopathic Urticaria
  • +4 more
  • Anniston, Alabama
  • +18 more
Nov 29, 2021

Post-Lumbar Puncture Headache Trial in Houston (Modified Lumbar Puncture)

Not yet recruiting
  • Post-Lumbar Puncture Headache
  • Modified Lumbar Puncture
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Oct 3, 2023

a Randomized Controlled Trial Trial in Fuzhou (Computerized Modified Paramedian Approach Technique, Conventional Midline

Not yet recruiting
  • a Randomized Controlled Trial
  • Computerized Modified Paramedian Approach Technique
  • Conventional Midline Approach Technique
  • Fuzhou, Fujian, China
    Fujian Medical University Union Hospital
Mar 31, 2023

Lymphedema Trial in Nice (lipoprotein (a))

Not yet recruiting
  • Lymphedema
  • lipoprotein (a)
  • Nice, Centre Antoine Lacassagne, France
    CAUSERET Marion
Jul 19, 2023

Colon Cancer Stage I Trial in Taoyuan (Magicell-NK contains NK cells suspended in 100 mL normal saline)

Recruiting
  • Colon Cancer Stage I
  • Magicell-NK contains NK cells suspended in 100 mL normal saline
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital, Linkou
Sep 28, 2022

GHD Trial (PEG-somatropin)

Not yet recruiting
  • GHD
  • (no location specified)
Sep 7, 2023

Transplant Complication, Diabetic Nephropathy, Perioperative/Postoperative Complications Trial in Guangzhou (Enhanced recovery

Completed
  • Transplant Complication
  • +2 more
  • Enhanced recovery for SPK recipients
  • Guangzhou, Guangdong, China
    Second affiliated hospital of Guangzhou Medical University
Oct 18, 2023

Status Asthmaticus Trial in Karachi (Magnesium Sulfate 500 mg/ml+ ventolin, Ventolin)

Enrolling by invitation
  • Status Asthmaticus
  • Magnesium Sulfate 500 mg/ml+ ventolin
  • Ventolin
  • Karachi, Sindh, Pakistan
    Rabia Asif
Feb 24, 2022

Cervical Degenerative Disc Disease, Radiculopathy, Myelopathy Trial in United States (PRESTIGE LP™ Cervical Disc)

Terminated
  • Cervical Degenerative Disc Disease
  • +2 more
  • PRESTIGE LP™ Cervical Disc
  • Beverly Hills, California
  • +3 more
Feb 1, 2023

Hemorrhagic Cystitis Trial in United States (LP-10)

Active, not recruiting
  • Hemorrhagic Cystitis
  • Tucson, Arizona
  • +8 more
Jan 9, 2023

Focal Segmental Glomerulosclerosis, Minimal Change Disease, Immunoglobulin A Nephropathy Trial in Worldwide (Sparsentan)

Recruiting
  • Focal Segmental Glomerulosclerosis
  • +4 more
  • Wilmington, Delaware
  • +32 more
Jan 10, 2023

Urologic Diseases, Surgery Trial (Laparoscopic pyeloplasty)

Not yet recruiting
  • Urologic Diseases
  • Surgery
  • Laparoscopic pyeloplasty
  • (no location specified)
Feb 28, 2023

Aveir AR Coverage With Evidence Development (CED) Study

Not yet recruiting
  • Cardiac Pacemaker
  • +2 more
  • Aveir AR Leadless Pacemaker
  • Single-chamber atrial transvenous pacemaker
  • (no location specified)
Oct 30, 2023

Amyotrophic Lateral Sclerosis Trial in Worldwide (AMX0035)

Enrolling by invitation
  • Amyotrophic Lateral Sclerosis
  • Leuven, Belgium
  • +42 more
Jan 20, 2023

Hiv Trial (LP-98 injection)

Not yet recruiting
  • Hiv
  • LP-98 injection
  • (no location specified)
Jun 27, 2023